Tandem Diabetes Care | TNDM - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 297M 2M 2026-09
Accuray USD 2.88M 72K 2024-12
Align Technology USD 9.96M 3.02M 2026-06
AtriCure USD 1.21M 159K 2026-03
Baxter International USD 64M 14M 2026-06
Becton, Dickinson and Co. USD 132M 17M 2026-06
Boston Scientific USD 100M 4M 2026-09
Cooper Companies USD 21.5M 600K 2026-06
Dexcom USD 3.1M 100K 2026-09
Edwards Lifesciences USD 30M 5.9M 2026-06
Eli Lilly USD 316M 201.3M 2026-09
Globus Medical USD 5.49B 48.7M 2026-06
ICU Medical USD 18.53M 2.11M 2026-03
Inogen 1.03M 384K 2025-03
Insulet USD 11M 3.7M 2026-06
Integra LifeSciences USD 22.96M 33K 2026-09
Intuitive Surgical USD 19.35B 1.53B 2026-09
J&J USD 43M 25M 2026-03
Medtronic USD 186M 10M 2026-06
Merit Medical Systems USD 7.33M 4.78M 2026-09
Orthofix International 4.68M 731K 2025-09
Roche Holding CHF 304M 7.5M 2025-06
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 27.95M 2.24M 2026-06
Zimmer Biomet Holdings USD 22.8B 22.73B 2026-06